An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

Earlier this month, NICE reiterated its position that Spravato should not be used for TRD, after an appeal of earlier rejections by J&J, with a final decision due in mid-December. In the ESCAPE ...

SPRAVATO® (esketamine): A prescription nasal ... community presence through a robust slate of Mental Health Awareness Month outreach initiatives, including: May 1 – Panel expert at a mental ...

ICER’s final report follows a draft version published last month that arrived at much the same conclusions. J&J’s Janssen unit – which markets Spravato – said at the time it disagreed with ...

Kansas City Psychiatry Partners is the leading Spravato clinic in the Kansas City Area. In this KANSAS CITY EXPERTS feature, ...

A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more ...